Page | 1
APEA- PSYCH PHARM EXAM 2025
BRAND NEW ACTUAL EXAM WITH
ANSWERS.
The most appropriate treatment for a patient diagnosed with
severe anorexia nervosa with delusional symptoms is:
an atypical antipsychotic, 2nd generation.
a benzodiazepine.
a selective serotonin receptor inhibitor (SSRI).
a serotonin-norepinephrine reuptake inhibitor (SNRI). - correct
answer -an atypical antipsychotic, 2nd generation.
Quetiapine (Seroquel) should NOT be prescribed during:
the depressive phase of bipolar disorder in a 65-year-old.
dementia-related psychosis in an older adult.
the manic phase of bipolar disease in adolescents.
schizophrenia in a 33-year-old woman. - correct answer -
dementia-related psychosis in an older adult.
, Page | 2
Fluoxetine (Prozac) is NOT approved as monotherapy for the
treatment of:
bipolar depression.
bulimia nervosa.
major depressive disorder.
panic disorder. - correct answer -bipolar depression.
Patients receiving selective serotonin reuptake inhibitors (SSRIs)
for the treatment of depression should be advised to take the
medication:
for a minimum of 3 months and then stop if symptoms have
resolved.
as directed and it will likely be required for life.
for a minimum of 6 months and to avoid abruptly stopping the
medication.
on an as needed basis if they are experiencing worsening
symptoms with daily use. - correct answer -for a minimum of 6
months and to avoid abruptly stopping the medication.
The mechanism of action of atomoxetine (Strattera), used in the
treatment of attention deficit disorder, is to:
selectively inhibit norepinephrine reuptake.
stimulate the release of the amphetamine peptide.
, Page | 3
block dopamine receptors.
desensitize pre-synaptic serotonin receptors. - correct answer -
selectively inhibit norepinephrine reuptake.
Ramelteon (Rozerem), a melatonin receptor agonist,:
is approved for treatment of restless leg syndrome.
does cause withdrawal symptoms if stopped abruptly.
is a controlled substance.
does not cause physical dependence. - correct answer -does not
cause physical dependence.
A patient has been receiving a monoamine oxidase inhibitor
(MAOI). How long before a selective serotonin receptor inhibitor
(SSRI) can be initiated?
At least 24 hours
3 days
7 days
14 days - correct answer -14 days
Laboratory monitoring for patients receiving serotonin-
norepinephrine reuptake inhibitors (SNRIs) would NOT include:
APEA- PSYCH PHARM EXAM 2025
BRAND NEW ACTUAL EXAM WITH
ANSWERS.
The most appropriate treatment for a patient diagnosed with
severe anorexia nervosa with delusional symptoms is:
an atypical antipsychotic, 2nd generation.
a benzodiazepine.
a selective serotonin receptor inhibitor (SSRI).
a serotonin-norepinephrine reuptake inhibitor (SNRI). - correct
answer -an atypical antipsychotic, 2nd generation.
Quetiapine (Seroquel) should NOT be prescribed during:
the depressive phase of bipolar disorder in a 65-year-old.
dementia-related psychosis in an older adult.
the manic phase of bipolar disease in adolescents.
schizophrenia in a 33-year-old woman. - correct answer -
dementia-related psychosis in an older adult.
, Page | 2
Fluoxetine (Prozac) is NOT approved as monotherapy for the
treatment of:
bipolar depression.
bulimia nervosa.
major depressive disorder.
panic disorder. - correct answer -bipolar depression.
Patients receiving selective serotonin reuptake inhibitors (SSRIs)
for the treatment of depression should be advised to take the
medication:
for a minimum of 3 months and then stop if symptoms have
resolved.
as directed and it will likely be required for life.
for a minimum of 6 months and to avoid abruptly stopping the
medication.
on an as needed basis if they are experiencing worsening
symptoms with daily use. - correct answer -for a minimum of 6
months and to avoid abruptly stopping the medication.
The mechanism of action of atomoxetine (Strattera), used in the
treatment of attention deficit disorder, is to:
selectively inhibit norepinephrine reuptake.
stimulate the release of the amphetamine peptide.
, Page | 3
block dopamine receptors.
desensitize pre-synaptic serotonin receptors. - correct answer -
selectively inhibit norepinephrine reuptake.
Ramelteon (Rozerem), a melatonin receptor agonist,:
is approved for treatment of restless leg syndrome.
does cause withdrawal symptoms if stopped abruptly.
is a controlled substance.
does not cause physical dependence. - correct answer -does not
cause physical dependence.
A patient has been receiving a monoamine oxidase inhibitor
(MAOI). How long before a selective serotonin receptor inhibitor
(SSRI) can be initiated?
At least 24 hours
3 days
7 days
14 days - correct answer -14 days
Laboratory monitoring for patients receiving serotonin-
norepinephrine reuptake inhibitors (SNRIs) would NOT include:
